Received: 6 December 2021
Accepted: 6 February 2022
First Online: 2 March 2022
: The present study has received ethical approval by the Comité de Protection des personnes on the 29th of novembre 2018 under the number 2017-A00613-50/SI: 18.09.12.65718. All patients have to give a written consent. All patients already included in the study have given a written consent.
: Not applicable.
: Prof. JM Regimbeau has financial interest with thermofisher.